Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review ; volume:23 ; number:1 ; day:28 ; month:9 ; year:2024 ; pages:1-20 ; date:12.2024
Cardiovascular diabetology ; 23, Heft 1 (28.9.2024), 1-20, 12.2024
- Creator
-
Zheng, Haixiang
Sechi, Leonardo Antonio
Navarese, Eliano Pio
Casu, Gavino
Vidili, Gianpaolo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-024-02434-5
- URN
-
urn:nbn:de:101:1-2412142113189.676191561102
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zheng, Haixiang
- Sechi, Leonardo Antonio
- Navarese, Eliano Pio
- Casu, Gavino
- Vidili, Gianpaolo
- SpringerLink (Online service)
Other Objects (12)
Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
The association between metabolic dysfunction-associated steatotic liver disease, cardiovascular and cerebrovascular diseases and the thickness of carotid plaque
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease and gallbladder polyp development: an observational study
A metabolic dysfunction-associated steatotic liver acinus biomimetic induces pancreatic islet dysfunction in a coupled microphysiology system
Helicobacter pylori infection exacerbates metabolic dysfunction-associated steatotic liver disease through lipid metabolic pathways: a transcriptomic study
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease
Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
The association between metabolic dysfunction-associated steatotic liver disease, cardiovascular and cerebrovascular diseases and the thickness of carotid plaque
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease and gallbladder polyp development: an observational study
A metabolic dysfunction-associated steatotic liver acinus biomimetic induces pancreatic islet dysfunction in a coupled microphysiology system
Helicobacter pylori infection exacerbates metabolic dysfunction-associated steatotic liver disease through lipid metabolic pathways: a transcriptomic study
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease
Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
The association between metabolic dysfunction-associated steatotic liver disease, cardiovascular and cerebrovascular diseases and the thickness of carotid plaque
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease and gallbladder polyp development: an observational study
A metabolic dysfunction-associated steatotic liver acinus biomimetic induces pancreatic islet dysfunction in a coupled microphysiology system
Helicobacter pylori infection exacerbates metabolic dysfunction-associated steatotic liver disease through lipid metabolic pathways: a transcriptomic study